Kelsall Jennett E, McCulley Stephen J, Brock Lisa, Akerlund Malin T E, Macmillan R Douglas
Nottingham Breast Institute, Nottingham City Hospital, Nottingham, NG5 1PB, United Kingdom.
Department of Plastic Surgery, Nottingham City Hospital, Nottingham, NG5 1PB, United Kingdom.
J Plast Reconstr Aesthet Surg. 2017 Oct;70(10):1377-1385. doi: 10.1016/j.bjps.2017.05.009. Epub 2017 May 18.
Oncoplastic breast conserving surgery (OBCS) allows women who may otherwise have mastectomy and immediate reconstruction (MxIR) the choice to conserve their breast yet avoid deformity. We compared the outcome of these options.
Two cohorts meeting study criteria were identified from prospectively audited series of women undergoing OBCS or MxIR. After case matching for age, tumour size and date of surgery, stratification by breast size and controlling for radiotherapy; body image scale (BIS) scores of psychosocial function and patient reported outcome measures (PROMs) for breast appearance and return to function were analysed.
A total of 567 women (286 treated by OBCS and 281 by MxIR) fulfilled inclusion criteria. Demographics were similar between the two unmatched cohorts, except for radiotherapy, age and tumour size (all p < 0.001). Overall, BIS score (p = 0.002), self-rated breast appearance, return to work and function (all p < 0.001) significantly favoured OBCS. Case-matched women with larger breasts treated by OBCS reported better BIS scores (mean 3.30 vs. 5.37, p = 0.011) and self-rated breast appearance score (p < 0.001) than MxIR, whereas no significant difference was observed for smaller breasts. BIS and appearance favoured OBCS, regardless of whether radiotherapy would have been avoided if treated by MxIR.
OBCS offers suitable women the option to avoid MxIR while providing faster recovery. Better psychosocial and self-rated satisfaction with breast appearance is achieved for OBCS in all groups, regardless of the need for radiotherapy, apart from those women with smaller breasts for whom the results are comparable.
肿瘤整形保乳手术(OBCS)使那些原本可能需要接受乳房切除及即刻重建(MxIR)的女性有机会保留乳房且避免乳房畸形。我们比较了这两种手术方式的结果。
从接受OBCS或MxIR的女性前瞻性审计系列中确定了两个符合研究标准的队列。在对年龄、肿瘤大小和手术日期进行病例匹配后,按乳房大小分层并控制放疗因素;分析心理社会功能的身体意象量表(BIS)评分以及患者报告的乳房外观和功能恢复的结局指标(PROMs)。
共有567名女性(286名接受OBCS治疗,281名接受MxIR治疗)符合纳入标准。除放疗、年龄和肿瘤大小外(均p<0.001),两个未匹配队列的人口统计学特征相似。总体而言,BIS评分(p=0.002)、自我评定的乳房外观、恢复工作和功能(均p<0.001)显著有利于OBCS。与MxIR相比,接受OBCS治疗的乳房较大的病例匹配女性报告的BIS评分更好(平均3.30对5.37,p=0.011)和自我评定的乳房外观评分更高(p<0.001),而乳房较小的女性未观察到显著差异。无论MxIR治疗是否可避免放疗,BIS和外观方面均有利于OBCS。
OBCS为合适的女性提供了避免MxIR的选择,同时恢复更快。所有组中,OBCS在心理社会和自我评定的乳房外观满意度方面表现更好,无论是否需要放疗,但乳房较小的女性结果相当。